Notice of major clinical trial results & Preliminary results
14-02-2005
LiDCO, the cardiovascular monitoring company announces that the results of a major trial using LiDCO’s technology to increase oxygen delivery in surgery patients at St George's Hospital, London, which concluded in September 2004, will be presented during the 25 th International Symposium on Intensive Care and Emergency Medicine in Brussels (21 st to 25 th March). This meeting is one of the year’s most important gatherings of the international intensive care community. The trial quantified the effect of increased oxygen delivery (Goal Directed Optimisation) on morbidity (organ damage and infection) and hospital bed days. The Board expects these results will be positive for the Company.
LiDCO will announce its preliminary results for the 13 months ended 31st January 2005 on Wednesday 30th March 2005.
Notes for Editors:
LiDCO is a leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients.
The Company’s current products are:
- the LiDCOplus and PulseCO monitors, computer-based platforms for displaying a range of real-time continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; and
- the LiDCO disposable for accurately determining cardiac output in a minimally-invasive manner.
Application of the LiDCO technology to reduce complications and costs of surgery:
Post surgical ‘Goal Directed Optimisation’ is an application of the LiDCOplus monitor. The ‘Goal’ is to target a higher than normal delivery of the oxygen carried by the blood’s red cells to the body tissues. Achievement of this ‘Goal’ has been shown to reduce the complications associated with surgery. To achieve ‘Goal Directed Optimisation’ the LiDCOplus monitor measures the absolute and beat to beat changing levels of oxygen delivery through use of an arterial line already inserted in a small vessel at the wrist of most major surgery patients. The monitor user interface has been specifically designed to help the clinician or nurse to rapidly and appropriately administer intra venous fluids and drugs that increase oxygen delivery to levels that ensure the repayment of any oxygen deficit incurred during major surgery. The advantages of using the LiDCOplus technology are that the oxygen delivery targets can be both set and achieved minimally invasively using existing staff without the use of more invasive catheters that have additional risks to the patient and costs to the hospital.
|
